Cambridge Laboratories, Valeant Pharmaceuticals International sales and marketing update

Cambridge Laboratories granted VRX rights to commercialize nabilone in the U.K. and the EU to treat chemotherapy-induced nausea and vomiting (CINV). Cambridge will receive $14 million up front. Nabilo...